nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloropyramine—PTK2—exocrine gland—uterine cancer	0.067	0.156	CbGeAlD
Chloropyramine—PTK2—myometrium—uterine cancer	0.0371	0.0866	CbGeAlD
Chloropyramine—PTK2—epithelium—uterine cancer	0.0291	0.068	CbGeAlD
Chloropyramine—PTK2—uterine cervix—uterine cancer	0.0289	0.0674	CbGeAlD
Chloropyramine—PTK2—smooth muscle tissue—uterine cancer	0.0281	0.0655	CbGeAlD
Chloropyramine—PTK2—decidua—uterine cancer	0.0275	0.0642	CbGeAlD
Chloropyramine—PTK2—renal system—uterine cancer	0.027	0.0631	CbGeAlD
Chloropyramine—PTK2—uterus—uterine cancer	0.0241	0.0562	CbGeAlD
Chloropyramine—PTK2—female reproductive system—uterine cancer	0.0216	0.0505	CbGeAlD
Chloropyramine—PTK2—female gonad—uterine cancer	0.0197	0.046	CbGeAlD
Chloropyramine—PTK2—vagina—uterine cancer	0.0196	0.0457	CbGeAlD
Chloropyramine—PTK2—lymph node—uterine cancer	0.0127	0.0296	CbGeAlD
Chloropyramine—HRH1—myometrium—uterine cancer	0.0116	0.027	CbGeAlD
Chloropyramine—HRH1—epithelium—uterine cancer	0.00909	0.0212	CbGeAlD
Chloropyramine—HRH1—uterine cervix—uterine cancer	0.00901	0.021	CbGeAlD
Chloropyramine—HRH1—smooth muscle tissue—uterine cancer	0.00876	0.0204	CbGeAlD
Chloropyramine—HRH1—decidua—uterine cancer	0.00859	0.02	CbGeAlD
Chloropyramine—HRH1—endometrium—uterine cancer	0.00815	0.019	CbGeAlD
Chloropyramine—HRH1—mammalian vulva—uterine cancer	0.00789	0.0184	CbGeAlD
Chloropyramine—HRH1—female reproductive system—uterine cancer	0.00675	0.0158	CbGeAlD
Chloropyramine—HRH1—female gonad—uterine cancer	0.00614	0.0143	CbGeAlD
Chloropyramine—HRH1—vagina—uterine cancer	0.00611	0.0143	CbGeAlD
Chloropyramine—HRH1—lymph node—uterine cancer	0.00395	0.00922	CbGeAlD
Chloropyramine—PTK2—Alpha 6 Beta 4 signaling pathway—HRAS—uterine cancer	0.00272	0.00477	CbGpPWpGaD
Chloropyramine—PTK2—Integrins in angiogenesis—CDKN1B—uterine cancer	0.0027	0.00473	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—SMAD3—uterine cancer	0.0027	0.00472	CbGpPWpGaD
Chloropyramine—PTK2—Signaling of Hepatocyte Growth Factor Receptor—HRAS—uterine cancer	0.00266	0.00465	CbGpPWpGaD
Chloropyramine—PTK2—Internalization of ErbB1—PIK3CA—uterine cancer	0.00263	0.0046	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—BIRC5—uterine cancer	0.00261	0.00456	CbGpPWpGaD
Chloropyramine—PTK2—IGF1 pathway—AKT1—uterine cancer	0.0026	0.00454	CbGpPWpGaD
Chloropyramine—PTK2—EPHB forward signaling—PIK3CA—uterine cancer	0.00258	0.00451	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events regulated by Ret tyrosine kinase—PIK3CA—uterine cancer	0.00258	0.00451	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—ERBB2—uterine cancer	0.00254	0.00444	CbGpPWpGaD
Chloropyramine—PTK2—Nongenotropic Androgen signaling—AKT1—uterine cancer	0.00253	0.00442	CbGpPWpGaD
Chloropyramine—PTK2—Internalization of ErbB1—HRAS—uterine cancer	0.00243	0.00426	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—uterine cancer	0.00243	0.00425	CbGpPWpGaD
Chloropyramine—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—CDKN1B—uterine cancer	0.00243	0.00425	CbGpPWpGaD
Chloropyramine—PTK2—Alpha 6 Beta 4 signaling pathway—AKT1—uterine cancer	0.00241	0.00421	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—uterine cancer	0.0024	0.0042	CbGpPWpGaD
Chloropyramine—PTK2—EPHB forward signaling—HRAS—uterine cancer	0.00238	0.00417	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events regulated by Ret tyrosine kinase—HRAS—uterine cancer	0.00238	0.00417	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—FGFR2—uterine cancer	0.00233	0.00408	CbGpPWpGaD
Chloropyramine—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—CTNNB1—uterine cancer	0.00229	0.00401	CbGpPWpGaD
Chloropyramine—PTK2—EPHB-mediated forward signaling—HRAS—uterine cancer	0.00229	0.00401	CbGpPWpGaD
Chloropyramine—PTK2—Integrins in angiogenesis—VEGFA—uterine cancer	0.00225	0.00393	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—MET—uterine cancer	0.00221	0.00387	CbGpPWpGaD
Chloropyramine—PTK2—Platelet Aggregation (Plug Formation)—AKT1—uterine cancer	0.0022	0.00384	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—KRAS—uterine cancer	0.00216	0.00378	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—IGF1R—uterine cancer	0.00214	0.00375	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—HNF1B—uterine cancer	0.00212	0.00371	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—uterine cancer	0.00211	0.0037	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—NRAS—uterine cancer	0.00211	0.0037	CbGpPWpGaD
Chloropyramine—PTK2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—uterine cancer	0.00211	0.00369	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CTNNB1—uterine cancer	0.00211	0.00369	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—NRAS—uterine cancer	0.00209	0.00365	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—CXCL8—uterine cancer	0.00204	0.00358	CbGpPWpGaD
Chloropyramine—PTK2—Cell-Cell communication—CDH1—uterine cancer	0.00194	0.00339	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—CTNNB1—uterine cancer	0.00194	0.00339	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—TP53—uterine cancer	0.00192	0.00336	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—PTEN—uterine cancer	0.00189	0.0033	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—CTNNB1—uterine cancer	0.00189	0.0033	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—HRAS—uterine cancer	0.00184	0.00321	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—uterine cancer	0.00182	0.00318	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by focal adhesion kinase—PIK3CA—uterine cancer	0.0018	0.00315	CbGpPWpGaD
Chloropyramine—PTK2—Fc-epsilon receptor I signaling in mast cells—PIK3CA—uterine cancer	0.0018	0.00315	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—EP300—uterine cancer	0.0018	0.00315	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—KRAS—uterine cancer	0.0018	0.00314	CbGpPWpGaD
Chloropyramine—PTK2—Integrins in angiogenesis—PIK3CA—uterine cancer	0.00176	0.00307	CbGpPWpGaD
Chloropyramine—PTK2—Angiopoietin receptor Tie2-mediated signaling—AKT1—uterine cancer	0.00173	0.00302	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—CDH1—uterine cancer	0.00168	0.00294	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—CTNNB1—uterine cancer	0.00167	0.00292	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—PIK3CA—uterine cancer	0.00167	0.00292	CbGpPWpGaD
Chloropyramine—PTK2—Fc-epsilon receptor I signaling in mast cells—HRAS—uterine cancer	0.00167	0.00292	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by VEGFR1 and VEGFR2—PIK3CA—uterine cancer	0.00165	0.00289	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—MET—uterine cancer	0.00165	0.00289	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—uterine cancer	0.00165	0.00288	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—VEGFA—uterine cancer	0.00163	0.00285	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—TP53—uterine cancer	0.00162	0.00283	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—HRAS—uterine cancer	0.0016	0.00281	CbGpPWpGaD
Chloropyramine—PTK2—RANKL/RANK Signaling Pathway—AKT1—uterine cancer	0.0016	0.0028	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—CTNNB1—uterine cancer	0.00158	0.00276	CbGpPWpGaD
Chloropyramine—PTK2—Caspase Cascade in Apoptosis—AKT1—uterine cancer	0.00155	0.00272	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—uterine cancer	0.00155	0.0027	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.00153	0.00267	CbGpPWpGaD
Chloropyramine—PTK2—Fc-epsilon receptor I signaling in mast cells—AKT1—uterine cancer	0.00147	0.00257	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—VEGFA—uterine cancer	0.00147	0.00257	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—NRAS—uterine cancer	0.00145	0.00254	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PIK3CA—uterine cancer	0.00145	0.00254	CbGpPWpGaD
Chloropyramine—PTK2—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CA—uterine cancer	0.00144	0.00251	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—IRF1—uterine cancer	0.00144	0.00251	CbGpPWpGaD
Chloropyramine—PTK2—Integrins in angiogenesis—AKT1—uterine cancer	0.00143	0.00251	CbGpPWpGaD
Chloropyramine—PTK2—Cell-Cell communication—CTNNB1—uterine cancer	0.00143	0.0025	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—AKT1—uterine cancer	0.00142	0.00248	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—HRAS—uterine cancer	0.00141	0.00247	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—PIK3CA—uterine cancer	0.00139	0.00244	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—VEGFA—uterine cancer	0.00139	0.00243	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—NRAS—uterine cancer	0.00137	0.0024	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—ERBB2—uterine cancer	0.00137	0.0024	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—AKT1—uterine cancer	0.00137	0.00239	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—uterine cancer	0.00135	0.00236	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—EP300—uterine cancer	0.00134	0.00235	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—uterine cancer	0.00134	0.00235	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—EP300—uterine cancer	0.00131	0.0023	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—IRF1—uterine cancer	0.00129	0.00226	CbGpPWpGaD
Chloropyramine—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—AKT1—uterine cancer	0.00129	0.00225	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—KRAS—uterine cancer	0.00125	0.00219	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—AKT1—uterine cancer	0.00125	0.00218	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—CTNNB1—uterine cancer	0.00124	0.00217	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—ERBB2—uterine cancer	0.00121	0.00211	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—uterine cancer	0.00118	0.00207	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—KRAS—uterine cancer	0.00118	0.00207	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—HRAS—uterine cancer	0.00118	0.00206	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—PTEN—uterine cancer	0.00117	0.00204	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—PIK3CA—uterine cancer	0.00115	0.00201	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—AKT1—uterine cancer	0.00114	0.00199	CbGpPWpGaD
Chloropyramine—PTK2—Integrin-mediated Cell Adhesion—HRAS—uterine cancer	0.00112	0.00196	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—NRAS—uterine cancer	0.00112	0.00195	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—AKT1—uterine cancer	0.00109	0.0019	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—PIK3CA—uterine cancer	0.00108	0.0019	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—MET—uterine cancer	0.00108	0.00188	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—HRAS—uterine cancer	0.00106	0.00186	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—AKT1—uterine cancer	0.00106	0.00185	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—CTNNB1—uterine cancer	0.00106	0.00185	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—PTEN—uterine cancer	0.00103	0.0018	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—HRAS—uterine cancer	0.001	0.00176	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—PIK3CA—uterine cancer	0.000994	0.00174	CbGpPWpGaD
Chloropyramine—PTK2—Integrin-mediated Cell Adhesion—AKT1—uterine cancer	0.000991	0.00173	CbGpPWpGaD
Chloropyramine—PTK2—Cell-Cell communication—PIK3CA—uterine cancer	0.000983	0.00172	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—KRAS—uterine cancer	0.00096	0.00168	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TP53—uterine cancer	0.00094	0.00164	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—AKT1—uterine cancer	0.000939	0.00164	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—SMAD3—uterine cancer	0.000938	0.00164	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—AKR1B10—uterine cancer	0.000931	0.00163	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—VEGFA—uterine cancer	0.000929	0.00163	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—KRAS—uterine cancer	0.000898	0.00157	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—AKT1—uterine cancer	0.000886	0.00155	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—PIK3CA—uterine cancer	0.000882	0.00154	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—TP53—uterine cancer	0.000826	0.00145	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	0.000824	0.00144	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—AKT1—uterine cancer	0.000812	0.00142	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—AKT1—uterine cancer	0.000794	0.00139	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—FGFR2—uterine cancer	0.00079	0.00138	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—ERBB2—uterine cancer	0.000787	0.00138	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—RNF43—uterine cancer	0.000772	0.00135	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—MET—uterine cancer	0.000769	0.00134	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—HRAS—uterine cancer	0.000763	0.00133	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IRF1—uterine cancer	0.000753	0.00132	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—PIK3CA—uterine cancer	0.000726	0.00127	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—INHBA—uterine cancer	0.000706	0.00123	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—AKT1—uterine cancer	0.000698	0.00122	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—FBXW7—uterine cancer	0.000674	0.00118	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—AKT1—uterine cancer	0.000674	0.00118	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—HRAS—uterine cancer	0.000672	0.00117	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	0.000643	0.00113	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—AKR1C1—uterine cancer	0.000635	0.00111	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—VEGFA—uterine cancer	0.000606	0.00106	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—NRAS—uterine cancer	0.000599	0.00105	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—AKT1—uterine cancer	0.000593	0.00104	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—ERBB2—uterine cancer	0.000562	0.000983	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—SOCS3—uterine cancer	0.000552	0.000966	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—AKT1—uterine cancer	0.000525	0.000919	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—KRAS—uterine cancer	0.000516	0.000902	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—ERBB2—uterine cancer	0.000496	0.000868	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—CTNNB1—uterine cancer	0.000492	0.00086	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—AKR1C3—uterine cancer	0.000489	0.000856	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.000486	0.00085	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—PGR—uterine cancer	0.000477	0.000834	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—AKR1B10—uterine cancer	0.000466	0.000816	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—FGFR2—uterine cancer	0.00046	0.000805	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CDKN1B—uterine cancer	0.00046	0.000804	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—EP300—uterine cancer	0.000457	0.000799	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—YWHAE—uterine cancer	0.000455	0.000796	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—EP300—uterine cancer	0.000448	0.000784	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—HRAS—uterine cancer	0.000438	0.000767	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—FBXW7—uterine cancer	0.000436	0.000763	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CTNNB1—uterine cancer	0.000434	0.000759	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—VEGFA—uterine cancer	0.000433	0.000757	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—NRAS—uterine cancer	0.000427	0.000748	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—VEGFA—uterine cancer	0.000425	0.000743	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—PTEN—uterine cancer	0.000423	0.00074	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—NRAS—uterine cancer	0.000419	0.000734	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—uterine cancer	0.000416	0.000728	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—EP300—uterine cancer	0.000404	0.000706	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—RNF43—uterine cancer	0.000386	0.000676	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000384	0.000672	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—STK11—uterine cancer	0.000381	0.000667	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—NRAS—uterine cancer	0.000377	0.00066	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—CCL2—uterine cancer	0.00037	0.000648	CbGpPWpGaD
Chloropyramine—HRH1—G alpha (q) signalling events—PIK3CA—uterine cancer	0.000368	0.000644	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—KRAS—uterine cancer	0.000368	0.000644	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—KRAS—uterine cancer	0.000361	0.000631	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	0.000358	0.000627	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—SOCS3—uterine cancer	0.000357	0.000624	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—INHBA—uterine cancer	0.000353	0.000618	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CDH1—uterine cancer	0.000343	0.000599	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CDKN2B—uterine cancer	0.000342	0.000598	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—IGF1R—uterine cancer	0.000332	0.00058	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—PIK3CA—uterine cancer	0.000332	0.00058	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	0.000329	0.000576	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—KRAS—uterine cancer	0.000325	0.000568	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—TP53—uterine cancer	0.000321	0.000561	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—AKR1C1—uterine cancer	0.000318	0.000557	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—HRAS—uterine cancer	0.000313	0.000547	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—SMAD3—uterine cancer	0.000312	0.000546	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—HRAS—uterine cancer	0.000307	0.000537	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	0.000305	0.000533	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—PIK3CA—uterine cancer	0.000298	0.000522	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—FGFR2—uterine cancer	0.000298	0.000521	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—CXCL8—uterine cancer	0.000293	0.000512	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—ERBB2—uterine cancer	0.000289	0.000506	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—HRAS—uterine cancer	0.000276	0.000483	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—AKT1—uterine cancer	0.000276	0.000483	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—AKT1—uterine cancer	0.000271	0.000474	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CDKN1B—uterine cancer	0.000268	0.000468	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—ESR1—uterine cancer	0.000255	0.000445	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CTNNB1—uterine cancer	0.000253	0.000442	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—PTEN—uterine cancer	0.000246	0.000431	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—AKR1C3—uterine cancer	0.000245	0.000429	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—AKT1—uterine cancer	0.000244	0.000427	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—PGR—uterine cancer	0.000239	0.000418	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—EP300—uterine cancer	0.000235	0.000411	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—YWHAE—uterine cancer	0.000228	0.000398	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CCL2—uterine cancer	0.000224	0.000392	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—NRAS—uterine cancer	0.00022	0.000385	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—FBXW7—uterine cancer	0.000218	0.000382	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—STK11—uterine cancer	0.000191	0.000334	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CCL2—uterine cancer	0.00019	0.000332	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—KRAS—uterine cancer	0.000189	0.000331	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—ERBB2—uterine cancer	0.000187	0.000327	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—SOCS3—uterine cancer	0.000179	0.000313	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CXCL8—uterine cancer	0.000177	0.00031	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—PIK3CA—uterine cancer	0.000174	0.000304	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CDKN1B—uterine cancer	0.000173	0.000303	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CDKN2B—uterine cancer	0.000171	0.000299	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—IGF1R—uterine cancer	0.000166	0.000291	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—CXCL8—uterine cancer	0.000165	0.000289	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CTNNB1—uterine cancer	0.000163	0.000286	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HRAS—uterine cancer	0.000161	0.000281	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—PTEN—uterine cancer	0.000159	0.000279	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—SMAD3—uterine cancer	0.000156	0.000273	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—EP300—uterine cancer	0.000152	0.000266	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CXCL8—uterine cancer	0.00015	0.000263	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—FGFR2—uterine cancer	0.000149	0.000261	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—VEGFA—uterine cancer	0.000144	0.000252	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—NRAS—uterine cancer	0.000142	0.000249	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—AKT1—uterine cancer	0.000142	0.000248	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—ESR1—uterine cancer	0.000127	0.000223	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—KRAS—uterine cancer	0.000122	0.000214	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—NRAS—uterine cancer	0.00012	0.000211	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—PIK3CA—uterine cancer	0.000112	0.000197	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CCL2—uterine cancer	0.000112	0.000196	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TP53—uterine cancer	0.000109	0.00019	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—PIK3CA—uterine cancer	0.000105	0.000184	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—HRAS—uterine cancer	0.000104	0.000182	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—KRAS—uterine cancer	0.000104	0.000181	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	9.53e-05	0.000167	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—ERBB2—uterine cancer	9.36e-05	0.000164	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—AKT1—uterine cancer	9.18e-05	0.000161	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CXCL8—uterine cancer	8.87e-05	0.000155	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—HRAS—uterine cancer	8.82e-05	0.000154	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	8.66e-05	0.000152	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	8.57e-05	0.00015	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	8.19e-05	0.000143	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—PTEN—uterine cancer	7.98e-05	0.00014	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—AKT1—uterine cancer	7.78e-05	0.000136	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—EP300—uterine cancer	7.61e-05	0.000133	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—VEGFA—uterine cancer	7.21e-05	0.000126	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—NRAS—uterine cancer	7.12e-05	0.000125	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—KRAS—uterine cancer	6.13e-05	0.000107	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	5.63e-05	9.85e-05	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TP53—uterine cancer	5.44e-05	9.53e-05	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—HRAS—uterine cancer	5.21e-05	9.11e-05	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—AKT1—uterine cancer	4.6e-05	8.04e-05	CbGpPWpGaD
